Skip to content

Population Health

Orchestrate and scale high-volume cancer screening and disease assessment programs

Please accept statistics and marketing cookies to watch this video.
Change consent

Aiming to enable earlier and more efficient cancer detection and to empower clinicians with information to make more accurate diagnoses for a wide variety of diseases

Book a demo

Improving cancer detection rates

76%

Of detected lung cancers found at earlier stages1

21%

Increase in breast cancer detection rate2

Reducing unnecessary recalls

Reduced single reader recall rate to expert level3

Driving operational and clinical excellence

10%

Reduction in reporting time for prostate scans4

92%

Sensitivity in detecting hippocampal atrophy5

Improving staff experience

Generalist radiologists elevated to expert levels6

Seamless scalability – easily accessible and quick to launch from any location

Explore our solutions

Want a closer look?
Let’s schedule a demo.
References: 1) New lung cancer screening roll out to detect cancer sooner - GOV.UK (www.gov.uk); 2) SmartMammo Dx + Assure used in a safeguard review process improved cancer detection rate by 21% in a study of over 575,000 patients, showing the same benefits across racial subgroups and patients with different breast densities. Data on file; 3) Data on file; 4) Cipollari et al., Radiologia Medica, 2022; 5) Asl Roma 2, "L’intelligenza artificiale a supporto della diagnosi precoce dei disturbi cognitivi in età geriatrica," 2024. Available here. 6) Faiella et al., Tomography, 2022;

Disclaimers: DeepHealth Lung is manufactured as Veye Lung Nodules by Aidence BV for DeepHealth Inc., DeepHealth Prostate is manufactured as Quantib Prostate by Quantib BV for DeepHealth Inc., and DeepHealth Brain is manufactured as Quantib ND by Quantib BV for DeepHealth Inc. Not all products and functionalities are commercially available in all countries. For clearance and commercial availability in your geography of functionalities listed and compatibility with other systems, please contact us.